- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Doctors to declare their earnings from pharma in affidavit, violations to bring 3-month suspension: NMC draft ethics guidelines
Overview
Announcing a crackdown on the doctor-pharma nexus that seems to be running in various forms across the country, the National Medical Commission in its recently issued "National Medical Commission Registered Medical Practitioner (Professional Conduct) Regulations, 2022" has laid down many points prohibiting doctors AND THEIR FAMILIES from taking any kinds of gifts or money from pharma and medical device companies, linking the same to a penalty that can go upto 3 months suspension.
The guidelines also state that doctors may have to file an affidavit declaring their financial earnings and or benefits received in the past 5 past years from any pharmaceutical companies or allied health sector.
For more details, check out the full story on the link below: